Skip to content

LivaNova LIVN Deferred Revenue

Deferred Revenue at other companies

Haemonetics logo
HaemoneticsHAE
$36.6M+9.9%
ITG
Integer HoldingsITGR
$5.38M+32.5%
ResMed logo
ResMedRMD
$179.28M+11.7%
Globus Medical logo
Globus MedicalGMED
$26.35M+53.4%
Medtronic logo
MedtronicMDT
Baxter International logo
Baxter InternationalBAX

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's deferred revenue?
LivaNova (LIVN) reported deferred revenue of $16.2M in Q1 2026.
How has LivaNova's deferred revenue changed year-over-year?
LivaNova's deferred revenue increased by 41.5% year-over-year, from $11.45M to $16.2M.
What is the long-term trend for LivaNova's deferred revenue?
Over 5 years (2020 to 2025), LivaNova's deferred revenue has grown at a 10.7% compound annual growth rate (CAGR), from $6.93M to $11.51M.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.